2A Pharma AB   Report issue

For profit Phase 1
Founded: Malmo Sweden (2016)

Organization Overview

First Clinical Trial
2019
NCT03929172
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

2A Pharma AB

Active Ingredients

Drugs in Phase 1 Trials (1)

aavlp-hpv (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Papillomavirus Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1